Discharge medications also differed significantly between groups (Table 2), with patients with AF being significantly more likely to receive clopidogrel, non-vitamin-K-antagonist oral anticoagulants, warfarin, aldosterone receptor antagonists, and diuretics and significantly less likely to receive aspirin, ticagrelor, or an angiotensin-converting enzyme inhibitor. Here, NR3C2 is linked to atrial fibrillation.